IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Cervical Dystonia

PHASE3CompletedINTERVENTIONAL
Enrollment

233

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

January 31, 2008

Study Completion Date

June 30, 2009

Conditions
Cervical Dystonia
Interventions
DRUG

incobotulinumtoxinA (Xeomin) (240 Units)

"incobotulinumtoxinA (Xeomin, also known as NT 201 or Botulinum toxin type A (150 kiloDalton), free from complexing proteins) (240 Units)"

DRUG

incobotulinumtoxinA (Xeomin) (120 Units)

"incobotulinumtoxinA (Xeomin, also known as NT 201 or Botulinum toxin type A (150 kiloDalton), free from complexing proteins) (120 Units)"

DRUG

Placebo

Placebo

Trial Locations (1)

Unknown

Dallas

Sponsors
All Listed Sponsors
lead

Merz Pharmaceuticals GmbH

INDUSTRY

NCT00407030 - IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Cervical Dystonia | Biotech Hunter | Biotech Hunter